Unknown

Dataset Information

0

IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells.

ABSTRACT:

Background

Natural killer (NK) cells are an emerging new tool for cancer immunotherapy. To develop NK cell therapeutics from peripheral blood mononuclear cells (PBMCs) of healthy donors, substantial expansion of primary NK cells is necessary because of the very low number of these cells in peripheral blood. In this study, we aimed to investigate the effect of various cytokine alone or combinations, in expanded NK cells and to analyze the synergetic effect of cytokine combinations.

Methods

Human NK cells were isolated from healthy donor PBMC. Purified NK cells were stimulated with single cytokines or combinations of IL-2, IL-15, IL-18, and IL-27. The expanded NK cells were characterized by flow cytometry, cytotoxicity assay, calcein AM assay and Western blot.

Results

We investigated the synergistic effects of each cytokine, namely, IL-2, IL-15, IL-18, and IL-27, on human NK cells isolated from PBMCs of healthy donors and cultured for 21 days. We identified that IL-15/IL-18/IL-27-mediated activation of NK cells most potently increased NK cell proliferation, cytotoxicity, and IFN-ɣ secretion compared with the activation observed with other treatments, including IL-2, IL-15, and IL-15/IL-18. Additionally, the expression of DNAM-1, NKG2D, CD69, and natural cytotoxicity receptors (NCRs; NKp30 and NKp44) increased on day 21 compared to that on day 0, demonstrating the activation of NK cells. In vitro, expanded NK cells were highly cytotoxic against cancer cells, displaying increased perforin and granzyme B accumulation.

Conclusions

Taken together, these results indicated that IL-27 can synergize on NK cell expansion and activation with IL-15 and IL-18. In addition, we described an improved culture method for ex vivo expansion of human NK cells with IL-15/IL-18/IL-27 stimulation and characterized the response of NK cells to this stimulation.

SUBMITTER: Choi YH 

PROVIDER: S-EPMC6612093 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown PDGF-D-PDGFRβ signaling enhances IL-15-mediated human natural killer cell survival.
| S-EPMC8784126 | biostudies-literature
Unknown Activity of IL-12/15/18 primed natural killer cells against hepatocellular carcinoma.
| S-EPMC6513806 | biostudies-literature
Unknown Ebola virus protein VP40 stimulates IL-12- and IL-18-dependent activation of human natural killer cells.
| S-EPMC9462474 | biostudies-literature
Unknown A novel fusion protein scaffold 18/12/TxM activates the IL-12, IL-15, and IL-18 receptors to induce human memory-like natural killer cells.
| S-EPMC8889352 | biostudies-literature
Unknown Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.
| S-EPMC3959288 | biostudies-literature
Unknown I?B? is essential for natural killer cell activation in response to IL-12 and IL-18.
| S-EPMC2955119 | biostudies-literature
Unknown Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
| S-EPMC4792546 | biostudies-literature
Unknown Environmental activation of a hypothalamic BDNF-adipocyte IL-15 axis regulates adipose-natural killer cells.
| S-EPMC8493653 | biostudies-literature
Transcriptomics Transcriptional changes in IL-2, IL-12 and IL-18 stimulated human natural killer cells
2010-08-05 | E-GEOD-22919 | biostudies-arrayexpress
Unknown Interleukin (IL)-18 Binding Protein Deficiency Disrupts Natural Killer Cell Maturation and Diminishes Circulating IL-18.
| S-EPMC5581878 | biostudies-literature